CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Alexion Pharmaceuticals, Inc. Company Snapshot
Alexion Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alexion Pharmaceuticals with three other companies in this sector in the United States: H. Lundbeck A/S (2016 sales of $2.32 billion ), Dr.Reddy's Laboratories Ltd ($2.36 billion of which 83% was Generics), and Mallinckrodt PLC ($3.38 billion of which 68% was Specialty Brands).

Sales Analysis. During the year ended December of 2016, sales at Alexion Pharmaceuticals were $3.08 billion. This is an increase of 18.4% versus 2015, when the company's sales were $2.60 billion. This was the fifth consecutive year of sales increases at Alexion Pharmaceuticals (and since 2011, sales have increased a total of 294%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Alexion Pharmaceuticals, Inc.
  Stock Performance Chart for Alexion Pharmaceuticals, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 119.26
(Figures in U.S. Dollars)
1 Week -2.3%   13 Weeks -9.3%  
4 Weeks -6.2%   52 Weeks -10.5%  
 
Alexion Pharmaceuticals, Inc. Key Data:
  Ticker: ALXN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 3,084,000,000
(Year Ending Jan 2017).
Employees: 3,121
  Currency: U.S. Dollars Market Cap: 26,787,435,825
  Fiscal Yr Ends: December Shares Outstanding: 224,613,750
  Share Type: Common Closely Held Shares: 786,371
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.